Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: In: Radiotherapy and Oncology, 127, 2, S. 246-252

Event: Veröffentlichung

(where): Augsburg

(who): Universität Augsburg

(when): 2018

Event: Veröffentlichung

(who): Elsevier BV

(when): 2018

Creator: Klement, R. J.
Hoerner-Rieber, J.
Adebahr, S.
Andratschke, Nicolaus
Blanck, O.
Boda-Heggemann, Judit
Duma, M.
Eble, M. J.
Eich, H. C.
Flentje, M.
Gerum, S.
Hass, P.
Henkenberens, C.
Hildebrandt, G.
Imhoff, D.
Kahl, Klaus-Henning
Klass, N. D.
Krempien, Robert
Lohaus, F.
Petersen, C.
Schrade, E.
Wendt, T. G.
Wittig, Andrea
Guckenberger, Matthias

DOI: 10.1016/j.radonc.2018.02.016

URN: urn:nbn:de:bvb:384-opus4-768371

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Klement, R. J.
Hoerner-Rieber, J.
Adebahr, S.
Andratschke, Nicolaus
Blanck, O.
Boda-Heggemann, Judit
Duma, M.
Eble, M. J.
Eich, H. C.
Flentje, M.
Gerum, S.
Hass, P.
Henkenberens, C.
Hildebrandt, G.
Imhoff, D.
Kahl, Klaus-Henning
Klass, N. D.
Krempien, Robert
Lohaus, F.
Petersen, C.
Schrade, E.
Wendt, T. G.
Wittig, Andrea
Guckenberger, Matthias
Universität Augsburg
Elsevier BV

Time of origin

2018

Other Objects (12)

Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT

Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma

Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases

Repeat sbrt for pulmonary oligo-metastases

Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)

Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)

Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments

Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma

Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases

PV-0044: repeat sbrt for pulmonary oligo-metastases

Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT

Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma

Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases

Repeat sbrt for pulmonary oligo-metastases

Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)

Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)

Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments

Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma

Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases

PV-0044: repeat sbrt for pulmonary oligo-metastases

Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT

Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma

Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases

Repeat sbrt for pulmonary oligo-metastases

Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)

Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)

Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments

Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma

Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases

PV-0044: repeat sbrt for pulmonary oligo-metastases

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT

Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma

Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases

Repeat sbrt for pulmonary oligo-metastases

Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)

Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)

Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments

Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma

Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases

PV-0044: repeat sbrt for pulmonary oligo-metastases

Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT

Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma

Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases

Repeat sbrt for pulmonary oligo-metastases

Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)

Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)

Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments

Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma

Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases

PV-0044: repeat sbrt for pulmonary oligo-metastases

Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT

Correction to: Stereotactic Ablative Radiotherapy (SABR/SBRT) for Hepatocellular Carcinoma

Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases

Repeat sbrt for pulmonary oligo-metastases

Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)

Treatment of metastatic breast cancer by stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS)

Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments

Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma

Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases

PV-0044: repeat sbrt for pulmonary oligo-metastases

Related objects

Reset password